Table 2. CELx HSP test results of 8 HER2- patient samples with healthy and HER2+ cell line.
HER2-Negative Patient Samples | Total NRG1 Signaling | Total EGF Signaling | Total HER- dependent Signaling | Total HER2-dependent Signaling from NRG1 | Total HER2- dependent Signaling from EGF | Test Measurand (Total HER2- dependent Signaling) | CELx Test Result |
---|---|---|---|---|---|---|---|
R39 | 634 | 294 | 928 | 475 | 88 | 563 | Abnormal |
R20 | 539 | 286 | 824 | 409 | 120 | 529 | Abnormal |
R160 | 349 | 229 | 578 | 332 | 99 | 430 | Abnormal |
R82 | 336 | 332 | 668 | 272 | 40 | 312 | Abnormal |
R95 | 250 | 116 | 366 | 227 | 44 | 271 | Abnormal |
R25 | 326 | 206 | 533 | 238 | 29 | 267 | Abnormal |
R71 | 336 | 211 | 547 | 228 | 23 | 252 | Abnormal |
R22 | 8 | 353 | 361 | 1 | 78 | 79 | Normal |
R62 Healthy | 32 | 13 | 46 | 31 | 7 | 38 | Normal |
SKBR3 cell line | 802 | 367 | 1169 | 401 | 143 | 544 | Abnormal |